Kennedy Ferruggia, Associate Editor

Ambient-UVB radiation could improve 25(OH)D prediction in the future, improving widespread vitamin D deficiencies among non-White individuals.

Durvalumab plus carboplatin and paclitaxel, continued with durvalumab monotherapy, decreased the risk of disease progression or death by 58%.

Data show that among individuals 60 years and older, the estimated rate of Guillain-Barré syndrome (GBS) after receiving an RSV vaccine was 5.0 and 1.5 per million doses of Abrysvo and Arexvy, respectively.

Donanemab was able to significantly slow clinical progression of Alzheimer disease and amyloid and tau pathology at 76 weeks of treatment.

A single dose of the vaccine showed long-lasting protection against RSV-associated lower respiratory tract disease in older adults.

Endocrine Society Guidelines suggest adults 75 years and older should take the recommended daily dose of vitamin D and are unlikely to benefit from more.

The study compares the safety and efficacy of mRNA-1345 compared to placebo.

Tools provide a safer testing option without using the viral proteins that cause infection.

Individuals from a lower socioeconomic group showed more benefits from low-dose CT screening relating to lung cancer survival.

If approved, zanidatamab will be the first HER2-targeted treatment indicated for individuals with this type of biliary tract cancer.

Researchers aimed to explore impacts of omega-3 fatty acids on children’s behavior, mood, and sleep.

The role of semaglutide as a glucagon-like peptide-1 (GLP-1) receptor antagonist could offer further treatment options to improve patient outcomes.

The results showed that during a 1-month hospital stay, 13% of individuals who experienced RSV-associated acute respiratory failure died.

The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.

The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.

Tarlatamab is a first-in-class immunotherapy that binds to DLL3 tumor cells and CD3 T-cells, to kill DLL3-expressing SCLC.

Three influencers from around the world showcase the passions they pursue outside the pharmacy industry.

Under the modification to the Food, Drug, & Cosmetics Act, individuals and health care providers can hopefully have more confidence in in vitro diagnostic devices.

SNB-101 is the first nanoparticle anticancer drug that was developed exceedingly insoluble SN-38 into polymer nanoparticles.

Ongoing and active shortages are currently at the highest number since January 2001.

Pharmacists can raise awareness for lung cancer during and after Lung Cancer Action Week.

The screenings should be conducted every other year, beginning at age 40 and continuing through age 74, according to the new recommendation.

Vitamin D deficiency (VDD) is an important factor in the pathogens of schizophrenia.

Trastuzumab is indicated for adjuvant breast cancer, metastatic breast cancer, and gastric cancer.

The severity of RSV disease among adults further highlights how crucial vaccine polices and recommendations are.

A 76% lower risk was displayed with adjuvant alectinib compared to chemotherapy treatment for non–small cell lung cancer.

Retinoic acid, an active form of vitamin A, is crucial for the stem cells to depart lineage plasticity which get separated into hair cells or epidermal cells in vitro.

The primary endpoint of the study was clinical remission at week 52 with vedolizumab

Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.

The results displayed well tolerability and safety with Abrysvo, meeting the study’s co-primary endpoint of immunogenicity and primary safety